Background: Atrial fibrillation (AF) is one of the most common arrhythmias, and is high
relative to cardiovascular morbidity and mortality. AF-related complications and treatment …

BACKGROUND: The renin–angiotensin–aldosterone system is suggested to play a key role
in the development of atrial fibrillation through structural and electrical remodeling. This …

Atrial fibrillation (AF) is a source of considerable morbidity and mortality. There has been
compelling evidence supporting the role of renin‐angiotensin system (RAS) in the genesis …

ATRIAL FIBRILLATION Clinical trials In the past 2 years, a number of landmark clinical trials
have been published which further our understanding and clinical management of patients …

Hypertension (1) and atrial fibrillation (2, 3) both increase with age. Both hypertension and
atrial fibrillation are associated with an increased incidence of stroke, heart failure, and …

Epidemiological studies have identified several differences in atrial fibrillation (AF) between
men and women. Men are more prone to AF at a younger age, probably due to larger left …

Introduction: Atrial remodelling, leading to atrial fibrillation (AF), is mediated by the renin–
angiotensin–aldosterone system. Methods: Mild hypertensive outpatients (systolic/diastolic …

Background. The renin‐angiotensin‐aldosterone‐system (RAAS) plays an important role in
atrial fibrillation (AF). Evidence shows that blocking the RAAS with angiotensin converting …

Background: Different antihypertensive drug classes may alter risk for atrial fibrillation. Some
studies suggest that drugs that interfere with the renin–angiotensin system may be favorable …

Atrial fibrillation (AF), the most common cardiac arrhythmia encountered in clinical practice,
is a growing public health problem. Atrial fibrillation currently affects more than two million …